Home › Funds › Saratoga Research & Investment Management › NVO
Saratoga Research & Investment Management position in NVO
NOVO-NORDISK A S · Health Care
Saratoga Research & Investment Management reported holding 3,181,453 shares of NVO (NOVO-NORDISK A S) in its Q3 2026 13F filing — a position valued at US$120.6M, representing 6.64% of its reported portfolio and ranking #5 among its reported holdings. Saratoga Research & Investment Management has disclosed NVO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR
How Saratoga Research & Investment Management's NVO position evolved
Saratoga Research & Investment Management first disclosed a stake in NVO in Q3 2023 at 890,165 shares (US$81.0M). The position peaked in Q2 2026 at 3,236,009 shares, worth US$155.1M. Across 13 filings, Saratoga Research & Investment Management increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,181,453 shares valued at US$120.6M — a reduction of -54,556 shares quarter over quarter.. Notable position changes include a 108% increase in Q1 2025 (shares were roughly flat over the following quarter), a 85% increase in Q1 2026 (shares rose 31% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 890.16K | $80.95M | New |
| Q4 2023 | 827.59K | $85.61M | Reduce |
| Q1 2024 | 783.79K | $100.64M | Reduce |
| Q2 2024 | 748.72K | $106.87M | Reduce |
| Q3 2024 | 708.52K | $84.36M | Reduce |
| Q4 2024 | 700.63K | $60.27M | Reduce |
| Q1 2025 | 1.45M | $100.98M | Add |
| Q2 2025 | 1.51M | $104.40M | Add |
| Q3 2025 | 1.85M | $102.86M | Add |
| Q4 2025 | 1.85M | $94.26M | Hold |
| Q1 2026 | 3.44M | $126.29M | Add |
| Q2 2026 | 3.24M | $155.13M | Reduce |
| Q3 2026 | 3.18M | $120.61M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVO and 13F data
NVO (NOVO-NORDISK A S) is a Health Care company. 15 other funds we track also report a position in NVO — the largest reported positions include LOOMIS SAYLES & CO L P (US$891.4M), FOLKETRYGDFONDET (US$456.5M), EVERETT HARRIS & CO /CA/ (US$310.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVO
- LOOMIS SAYLES & CO L P 18.59M sh · $891.41M · Q2 2026
- FOLKETRYGDFONDET 9.52M sh · $456.50M · Q2 2026
- EVERETT HARRIS & CO /CA/ 6.48M sh · $310.44M · Q2 2026
More on Saratoga Research & Investment Management
FAQ
How long has Saratoga Research & Investment Management held NVO?
Saratoga Research & Investment Management has disclosed NVO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Saratoga Research & Investment Management's current position in NVO?
As of Q3 2026, Saratoga Research & Investment Management holds 3.18M shares of NVO (NOVO-NORDISK A S), valued at $120.61M, representing 6.64% of its reported portfolio and ranking #5.
Has Saratoga Research & Investment Management been buying or selling NVO?
In the latest 13F filing (Q3 2026), Saratoga Research & Investment Management reduced its position in NVO. The position peaked in Q2 2026 at 3.24M shares.
Which other funds hold NVO?
Other major institutional holders of NVO include LOOMIS SAYLES & CO L P, FOLKETRYGDFONDET, EVERETT HARRIS & CO /CA/, among 15 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.